Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort ascending

Hani Oweira, Anway Giryes, Meinrad Mannhart, Michael Decker, and Omar Abdel-Rahman

 August 2018 Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials Expert Review of Gastroenterology and Hepatology

Omar Abdel-Rahman

 July 2018 Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study Expert Opinion on Drug Safety

Michael A. Webster-Clark, Hanna K. Sanoff, Til Stürmer, Sharon Peacock Hinton, Jennifer L. Lund

 January 2019 Diagnostic Assessment of Assumptions for External Validity - An Example Using Data in Metastatic Colorectal Cancer Epidemiology

Timothe Menard, Bjorn Koneswarakantha, Donato Rolo, Yves Barmaz, Leszek Popko, Rich Bowling

 December 2019 Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety

Omar Abdel-Rahman

 December 2018 Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials Clinical Breast Cancer

Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang

 June 2018 Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study Cancer Medicine

Omar Abdel-Rahman

 June 2018 Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy Breast Cancer

Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart

 October 2019 The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort BMC Medicine

Omar Abdel-Rahman, Winson Y. Cheung

 January 2018 External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International

Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley,  Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang,  Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson,  John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger

 September 2021 Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma American Association for Cancer Research

Jiawei Zhou, Yutong Liu, Yubo Zhang, Quefeng Li and Yanguang Cao

 November 2019 Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer; a retrospective analysis American Association for Cancer Research

Louis Dron, Shirin Golchi, Grace Hsu, Kristian, Thorlund

 September 2019 Minimizing Control Group Allocation in Randomized Trials Using Dynamic Borrowing of External Control Data – An Application to Second Line Therapy for Non-Small Cell Lung Cancer Contemporary Clinical Trials Communications

Fionán Donohoea, Yvonne O'Mearaa, AidinRoberts, Louise Comerford, Catherine M. Kelly, JaniceM. Walshe, Michelle Peate, Marth aHickey, Donal J.Brennan

 November 2021 The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study Contemporary Clinical Trials Communications

Steven B.Cohen, Jennifer Unangst, Feng Yu

 November 2020 Enhancing the analytic utility of clinical trial data to inform health disparities research Contemporary Clinical Trials Communications

Pages